Agenus Inc (AGEN)
7.41
+0.95
(+14.71%)
USD |
NASDAQ |
Apr 24, 16:00
7.45
+0.04
(+0.54%)
After-Hours: 20:00
Agenus Net Income (TTM): -245.76M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -245.76M |
| September 30, 2023 | -270.56M |
| June 30, 2023 | -262.58M |
| March 31, 2023 | -240.00M |
| December 31, 2022 | -220.07M |
| September 30, 2022 | -209.09M |
| June 30, 2022 | 21.14M |
| March 31, 2022 | -15.72M |
| December 31, 2021 | -21.07M |
| September 30, 2021 | 1.428M |
| June 30, 2021 | -225.73M |
| March 31, 2021 | -189.92M |
| December 31, 2020 | -180.91M |
| September 30, 2020 | -173.36M |
| June 30, 2020 | -167.68M |
| March 31, 2020 | -170.84M |
| December 31, 2019 | -107.66M |
| September 30, 2019 | -125.36M |
| June 30, 2019 | -113.01M |
| March 31, 2019 | -87.04M |
| December 31, 2018 | -159.69M |
| September 30, 2018 | -146.97M |
| June 30, 2018 | -150.69M |
| March 31, 2018 | -157.73M |
| December 31, 2017 | -120.69M |
| Date | Value |
|---|---|
| September 30, 2017 | -111.78M |
| June 30, 2017 | -115.71M |
| March 31, 2017 | -112.32M |
| December 31, 2016 | -127.00M |
| September 30, 2016 | -116.48M |
| June 30, 2016 | -88.83M |
| March 31, 2016 | -100.92M |
| December 31, 2015 | -87.88M |
| September 30, 2015 | -98.25M |
| June 30, 2015 | -93.24M |
| March 31, 2015 | -60.87M |
| December 31, 2014 | -42.49M |
| September 30, 2014 | -22.29M |
| June 30, 2014 | -21.49M |
| March 31, 2014 | -24.60M |
| December 31, 2013 | -30.07M |
| September 30, 2013 | -29.74M |
| June 30, 2013 | -28.15M |
| March 31, 2013 | -23.93M |
| December 31, 2012 | -11.32M |
| September 30, 2012 | -11.91M |
| June 30, 2012 | -11.71M |
| March 31, 2012 | -10.54M |
| December 31, 2011 | -23.28M |
| September 30, 2011 | -19.67M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-270.56M
Minimum
Sep 2023
21.14M
Maximum
Jun 2022
-153.51M
Average
-173.36M
Median
Sep 2020
Net Income (TTM) Benchmarks
| Protalix BioTherapeutics Inc | 8.312M |
| InfuSystems Holdings Inc | 0.872M |
| PAVmed Inc | -64.18M |
| Allogene Therapeutics Inc | -327.26M |
| Pfizer Inc | 2.119B |